Number of Shares
70,000.00
Current Holdings Value*
$2.73 Mil
% of Portfolio
0.39%
Total Estimate Gain
$885,500.00
% of Total Estimate Gain
29.36%

Macquarie Healthcare Fund's MoonLake Immunotherapeutics Holding Summary

As of 2025-03-31, Macquarie Healthcare Fund held 70,000.00 shares of MoonLake Immunotherapeutics(MLTX), totaling $2.73 Mil. This investment constitutes 0.39% of their stock portfolio, and Macquarie Healthcare Fund now holds 0.11% of the outstanding MoonLake Immunotherapeutics(MLTX) stock.

The initial trade took place in 2025Q1. And since then Macquarie Healthcare Fund has made 1 purchases of MLTX, at an average price of $43.09, for a total of 70,000.00 shares. Based on historical transaction data and MLTX's current price of $55.74, Macquarie Healthcare Fund's estimated gain on his MLTX holdings is $885,500.00, reflecting a 29.36% gain to date.

Macquarie Healthcare Fund MLTX ($55.74) Holding Chart

Macquarie Healthcare Fund MLTX ($55.74) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1